- Contract Packaging
- Leaders in Packaging
Article | March 31, 1997
FDA proposes OTC drug label overhaul
The Food and Drug Administration has proposed a new easy-to-understand label for the nearly 100ꯠ brand-name and private-label OTC drugs it regulates.
The new format will enable consumers to tell at a glance the proper use of the drug its side effects and when to see a doctor before using. Comparisons among drugs will also be easier. Some companies already use a simplified label but FDA wants a uniform format that is easily recognized and understood by consumers Dr. Ilisa Bernstein an FDA senior science policy advisor tells Packaging World. The proposed makeover continues a strategy that FDA began six years ago in requiring improved nutrition labeling on food packaging. The uniform labeling format has standard graphics subheadings a standardized order of information a 6-point minimum typesize a specific type style and simplified language. Warnings are more prominent to reduce adverse drug reactions caused by improper use. The label would appear on the secondary packaging such as a folding carton containing a bottle or on the bottle itself if there is no carton. The proposal published in late February 1997 includes a four-month comment period with a final rule expected by the end of 1997. Drug manufacturers would have two years to comply or three years for lower-volume products with less than $25 in annual sales.
Related Sponsored Content
E-BOOK SPECIAL REPORT
The 2014 Packaging Trends Report
Sign up to receive timely updates from our editors and download this e-book consisting of our editors' picks of most notable package designs. Updated for 2014!